bisindolylmaleimide i has been researched along with Hyperplasia in 2 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Palazzo, E | 1 |
Kellett, MD | 1 |
Cataisson, C | 1 |
Bible, PW | 1 |
Bhattacharya, S | 1 |
Sun, HW | 1 |
Gormley, AC | 1 |
Yuspa, SH | 1 |
Morasso, MI | 1 |
Willis, AI | 1 |
Fuse, S | 1 |
Wang, XJ | 1 |
Chen, E | 1 |
Tuszynski, GP | 1 |
Sumpio, BE | 1 |
Gahtan, V | 1 |
2 other studies available for bisindolylmaleimide i and Hyperplasia
Article | Year |
---|---|
A novel DLX3-PKC integrated signaling network drives keratinocyte differentiation.
Topics: Animals; Antimicrobial Cationic Peptides; Calcium; Cell Adhesion; Cell Differentiation; Cell Prolife | 2017 |
Inhibition of phosphatidylinositol 3-kinase and protein kinase C attenuates extracellular matrix protein-induced vascular smooth muscle cell chemotaxis.
Topics: Animals; Cattle; Cell Count; Cell Division; Cells, Cultured; Chemotaxis; Chromones; Enzyme Inhibitor | 2000 |